https://www.neurologylive.com/view/rebound-relapse-effect-identified-nmosd-discontinuation-eculizumab-discontinuation
In this small-scale Turkish-based substudy, stopping eciluzumab appeared to be associated with a “rebound” effect with a high risk of relapse in patients with NMOSD.
Create an account
or login to join the discussion